Application Note: A New Technology For In Vitro Chemotaxis Assays
11 February 2019

The development of genetically engineered T cells to produce chimeric antigen receptors on their surface is a promising approach in the field of immune-oncology. Evaluation of the function and activity of these modified cells, including cell migration an essential component of immune response, are required to optimize clinical outcome.